{
  "Q0": "Whole genome sequencing (WGS)",
  "Q1": "Yes",
  "Q2": "No",
  "Q3": "No",
  "Q4": "No",
  "Q5": "No",
  "Q6": "No",
  "Q7": "No",
  "Q8": "Yes",
  "Q8_detail": "A more targeted test, such as chromosomal microarray (CMA) or a neurodevelopmental disorder panel, would be more appropriate as a first-line test according to the policy.",
  "Q9": "Yes",
  "Q9_detail": "No",
  "Q10": "No",
  "Q10_detail": "Diagnostic",
  "Q11": "Yes",
  "Q12": "No",
  "Q13": "Not specified",
  "Q14": "Yes",
  "Q14_detail": "81425 (Genome; sequence analysis)",
  "Q15": "No",
  "Q16": "No",
  "Q17": "To submit a claim for genetic testing under this policy, the following steps must be followed: (1) Ensure that all prerequisite evaluations (such as chromosomal microarray and relevant targeted panels) have been completed and are negative or inconclusive; (2) Confirm that the test is ordered by a Board-Certified or Board-Eligible Medical Geneticist or an appropriate independent provider as defined by the policy; (3) Provide documentation that the test will directly impact clinical management; (4) Submit all required clinical documentation, including genetic counseling notes, to support medical necessity; (5) Use the appropriate CPT code (e.g., 81425 for WGS) and include all supporting documentation with the claim.",
  "match": true
}